Activating Compound | Comment | Organism | Structure |
---|---|---|---|
1-(1-(4-chlorophenyl)cyclohexyl)-3-(thiazol-2-yl)urea | - |
Homo sapiens | |
2-amino-4-fluoro-5-((1-methyl-1H-imidazol-2-yl)thio)-N-(thiazol-2-yl)benzamide | - |
Homo sapiens | |
2-amino-4-fluoro-5-(1,3,4-thiadiazol-2-ylsulfanyl)-N-(3-trifluoromethyl-phenyl)-benzamide | 1.14fold activation at 0.01 mM | Homo sapiens | |
2-amino-4-fluoro-5-(1-methyl-1H-imidazol-2-ylsulfanyl)-N-(3-trifluoromethyl-phenyl)-benzamide | 1.47fold activation at 0.01 mM | Homo sapiens | |
2-amino-4-fluoro-5-(4-methyl-thiazol-2-ylsulfanyl)-N-(3-trifluoromethyl-phenyl)-benzamide | 0.89fold activation at 0.01 mM | Homo sapiens | |
2-amino-4-fluoro-5-(thiazol-2-ylsulfanyl)-N-(3-trifluoromethyl-phenyl)-benzamide | 1.15fold activation at 0.01 mM | Homo sapiens | |
2-amino-4-fluoro-N-(3-fluoro-phenyl)-5-(1,3,4-thiadiazol-2-ylsulfanyl)-benzamide | 1.36fold activation at 0.01 mM | Homo sapiens | |
2-amino-4-fluoro-N-(3-fluoro-phenyl)-5-(1-methyl-1Himidazol-2-ylsulfanyl)-benzamide | 2.04fold activation at 0.01 mM | Homo sapiens | |
2-amino-4-fluoro-N-(3-fluoro-phenyl)-5-(pyridin-2-ylsulfanyl)-benzamide | 1.1fold activation at 0.01 mM | Homo sapiens | |
2-amino-4-fluoro-N-(3-fluoro-phenyl)-5-(thiazol-2-ylsulfanyl)-benzamide | 1.25fold activation at 0.01 mM | Homo sapiens | |
2-amino-4-fluoro-N-(3-methoxy-phenyl)-5-(1-methyl-1H-imidazol-2-ylsulfanyl)-benzamide | 1.15fold activation at 0.01 mM | Homo sapiens | |
2-amino-4-fluoro-N-(4-methoxy-phenyl)-5-(1-methyl-1H-imidazol-2-ylsulfanyl)-benzamide | 2.01fold activation at 0.01 mM | Homo sapiens | |
2-amino-5-(benzoxazol-2-ylsulfanyl)-4-fluoro-N-(3-fluoro-phenyl)-benzamide | 0.83fold activation at 0.01 mM | Homo sapiens | |
2-amino-N-(3,4-dimethoxy-phenyl)-4-fluoro-5-(1-methyl-1H-imidazol-2-ylsulfanyl)-benzamide | 1.32fold activation at 0.01 mM | Homo sapiens | |
2-amino-N-(3-amino-phenyl)-4-fluoro-5-(1,3,4-thiadiazol-2-ylsulfanyl)-benzamide | 1.22fold activation at 0.01 mM | Homo sapiens | |
2-amino-N-(3-amino-phenyl)-4-fluoro-5-(1-methyl-1H-imidazol-2-ylsulfanyl)-benzamide | 2.09fold activation at 0.01 mM | Homo sapiens | |
2-amino-N-(3-amino-phenyl)-4-fluoro-5-(4-methylthiazol-2-ylsulfanyl)-benzamide | 1.1fold activation at 0.01 mM | Homo sapiens | |
2-amino-N-(3-amino-phenyl)-4-fluoro-5-(pyridin-2-ylsulfanyl)-benzamide | 1.12fold activation at 0.01 mM | Homo sapiens | |
2-amino-N-(3-amino-phenyl)-4-fluoro-5-(thiazol-2-ylsulfanyl)-benzamide | 1.21fold activation at 0.01 mM | Homo sapiens | |
2-amino-N-(3-amino-phenyl)-5-(4,6-dimethyl-pyrimidin-2-ylsulfanyl)-4-fluoro-benzamide | 1.09fold activation at 0.01 mM | Homo sapiens | |
2-amino-N-(3-aminomethyl-phenyl)-4-fluoro-5-(1-methyl-1H-imidazol-2-ylsulfanyl)-benzamide | 1.01fold activation at 0.01 mM | Homo sapiens | |
2-amino-N-(3-cyano-phenyl)-4-fluoro-5-(1,3,4-thiadiazol-2-ylsulfanyl)-benzamide | 1.2fold activation at 0.01 mM | Homo sapiens | |
2-amino-N-(3-cyano-phenyl)-4-fluoro-5-(1-methyl-1Himidazol-2-ylsulfanyl)-benzamide | 1.95fold activation at 0.01 mM | Homo sapiens | |
2-amino-N-(3-cyano-phenyl)-4-fluoro-5-(4-methylthiazol-2-ylsulfanyl)-benzamide | 0.99fold activation at 0.01 mM | Homo sapiens | |
2-amino-N-(3-cyano-phenyl)-4-fluoro-5-(thiazol-2-ylsulfanyl)-benzamide | 1.2fold activation at 0.01 mM | Homo sapiens | |
2-amino-N-(3-cyano-phenyl)-5-(4,6-dimethyl-pyrimidin-2-ylsulfanyl)-4-fluoro-benzamide | 1.01fold activation at 0.01 mM | Homo sapiens | |
2-cyclopentyl-1-(4-(methylsulfonyl)phenyl)-N-(thiazol-2-yl)ethanesulfonamide | - |
Homo sapiens | |
2-[4-(2,4-difluoro-phenyl)-piperazin-1-yl]-N-(3,4-dimethoxy-phenyl)-acetamide | 1.01fold activation at 0.01 mM | Homo sapiens | |
2-[4-(2-fluoro-phenyl)-piperazin-1-yl]-N-(3-trifluoromethyl-phenyl)-acetamide | 1.06fold activation at 0.01 mM | Homo sapiens | |
3-(5-chlorothiazol-2-yl)-1-(4-(methylsulfonyl)phenyl)-1-(thiophen-3-ylmethyl)urea | - |
Homo sapiens | |
3-amino-N-[2-amino-4-fluoro-5-(1-methyl-1H-imidazol-2-ylsulfanyl)-phenyl]-benzamide | 1.16fold activation at 0.01 mM | Homo sapiens | |
LY-2121260 | - |
Homo sapiens | |
N,N'-bis-(2-methoxy-phenyl)-isophthalamide | 1.02fold activation at 0.01 mM | Homo sapiens | |
N,N'-bis-(3-methoxy-phenyl)-isophthalamide | 0.81fold activation at 0.01 mM | Homo sapiens | |
N,N'-bis-(4-methoxy-phenyl)-isophthalamide | 0.89fold activation at 0.01 mM | Homo sapiens | |
N-(3-amino-phenyl)-2-[4-(2-fluoro-phenyl)-piperazin-1-yl]-acetamide | 1.08fold activation at 0.01 mM | Homo sapiens | |
N-(3-cyano-phenyl)-2-[4-(2-fluoro-phenyl)-piperazin-1-yl]-acetamide | 0.96fold activation at 0.01 mM | Homo sapiens | |
N-(3-fluoro-phenyl)-2-[4-(2-fluoro-phenyl)-piperazin-1-yl]-acetamide | 1.01fold activation at 0.01 mM | Homo sapiens | |
RO-0281675 | - |
Homo sapiens |
Cloned (Comment) | Organism |
---|---|
expressed in Escherichia coli BL21(DE3) cells | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Purification (Comment) | Organism |
---|---|
Ni-NTA column chromatography | Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
liver | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + D-glucose | - |
Homo sapiens | ADP + D-glucose 6-phosphate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
glucokinase | - |
Homo sapiens |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ATP | - |
Homo sapiens |